TYK Medicines (HKSE:02410) Net Issuance of Preferred Stock : HK$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

TYK Medicines's net issuance of preferred for the three months ended in Dec. 2024 was HK$0.00 Mil. The number is 0, which means that TYK Medicines has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

TYK Medicines's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.

TYK Medicines Net Issuance of Preferred Stock Historical Data

The historical data trend for TYK Medicines's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines Net Issuance of Preferred Stock Chart

TYK Medicines Annual Data

Trend

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

TYK Medicines Quarterly Data
	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial			-	-	-	-	-

TYK Medicines Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

TYK Medicines Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of TYK Medicines's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

TYK Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN

Website

https://www.tykmedicines.com

TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with 12 drug candidates, including Core Product TY-9591, seven products in the clinical stage, and four products in the preclinical stage or early clinical development stage.

Executives

Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng	2201 Interest of corporation controlled by you
Zhu Julia Ming	2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si	2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
He Chao	2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

TYK Medicines Headlines

No Headlines